Analgesic spray recalled on a chemical cancer cancer, warns the FDA
You may want to check your pharmacy cabinet for this product.
Most of our Pharmacy cabinets are full of all kinds of products that can help relieve pain for minor cuts, scratches, burns, sunburns, etc. But the next time you reach a particular product, be very careful: the Food and Drug Administration of the United States (FDA) now warns that an analgesic spray is recalled by a chemical cancer cancer.
In relation: Spray of the athlete's foot recalled on a chemical cancer cancer, the FDA warns
On December 22, the FDA shared a company announcement Of Insight Pharmaceuticals concerning the latest medical recall. According to the alert, the company "voluntarily recalls" a batch of its topical anesthetic spray of Benzocaine American in terms of consumers. AE0FCC31AE342FD3A1346EBB1F342FCB
The affected product is the maximum resistance formula at 20%, which is packed in white aerosol cans with Turacian caps. The batch recalled to code 1A16420, which you can find located at the bottom of the box.
"Above all, no other batch of American with 20% of anesthetic topical benzocaine (before or after this code by lots) is within the framework of this recall and can continue to be used by consumers safely and as planned" , noted the company in its ad.
But why does Insight Pharmaceuticals remember this lot of his analgesic spray? According to the reminder announcement, the packaging of the affected product has proven to contain a chemical cancer cancer: benzene.
"While benzene is not an ingredient in the 20%Benzocaine anesthetic spraying products, a recent review of our manufacturer and their third -party laboratory revealed that a sample of a lot of the product has shown That a low level of benzene came from the organization this explains the product outside the box, "said the company.
In relation: Blood pressure medications recalled after oxycodone found inside, the FDA warns .
As the The FDA explains , "Benzene is a known human carcinogen that causes leukemia and other blood disorders." The agency recently evaluated the risk of benzene contamination in certain products, noting that several other aerosol drug products have been recalled due to contamination linked to spraying propellants.
“Exposure to benzene can occur by inhalation, orally, and through the skin and it can potentially cause cancers, including leukemia and blood -mooding blood and blood disorders that can be fatal. Caution, "said the company in its reminder advertisement.
There have not yet been serious adverse events linked to the recall of the topical anesthetics of American benzocaine. However, Insight said that he had informed the retailers to withdraw the reminded products remaining from his shelves. The company also agreed to "offer a refund to consumers" who bought their marked spraying of the affected lot code.
You can contact Insight Pharmaceuticals with an image from the bottom of the box to receive a full refund. "Consumers who have products that are recalled must stop using the product immediately and appropriately after taking the photo," added the company. "Consumers must contact their doctor or health care provider if they have encountered problems that may be linked to the taking or the use of this anesthetic product."
In relation: For more information, register for our daily newsletter .
